Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.

Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, Brennan FM, Foxwell BM.

J Immunol. 2008 Dec 1;181(11):8002-9.

PMID:
19017992
[PubMed - indexed for MEDLINE]
Free Article
2.

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis.

Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, Sibilia J.

Arthritis Res Ther. 2010;12(4):R135. doi: 10.1186/ar3073. Epub 2010 Jul 8.

PMID:
20615213
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.

Woolley DE, Tetlow LC.

Arthritis Res. 2000;2(1):65-74.

PMID:
11219391
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.

Arthritis Rheum. 2004 May;50(5):1457-67.

PMID:
15146415
[PubMed - indexed for MEDLINE]
Free Article
5.

Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures.

Ultaigh SN, Saber TP, McCormick J, Connolly M, Dellacasagrande J, Keogh B, McCormack W, Reilly M, O'Neill LA, McGuirk P, Fearon U, Veale DJ.

Arthritis Res Ther. 2011 Feb 23;13(1):R33. doi: 10.1186/ar3261.

PMID:
21345222
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

TLR activation pathways in HIV-1-exposed seronegative individuals.

Biasin M, Piacentini L, Lo Caputo S, Naddeo V, Pierotti P, Borelli M, Trabattoni D, Mazzotta F, Shearer GM, Clerici M.

J Immunol. 2010 Mar 1;184(5):2710-7. doi: 10.4049/jimmunol.0902463. Epub 2010 Feb 1.

PMID:
20124101
[PubMed - indexed for MEDLINE]
Free Article
7.

[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].

Seemayer CA, Distler O, Kuchen S, Müller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S.

Z Rheumatol. 2001 Oct;60(5):309-18. Review. German.

PMID:
11759230
[PubMed - indexed for MEDLINE]
8.

Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.

Abdollahi-Roodsaz S, Joosten LA, Helsen MM, Walgreen B, van Lent PL, van den Bersselaar LA, Koenders MI, van den Berg WB.

Arthritis Rheum. 2008 Dec;58(12):3753-64. doi: 10.1002/art.24127.

PMID:
19035506
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.

Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, Sytwu HK, Chang DM.

Rheumatology (Oxford). 2007 Aug;46(8):1266-73. Epub 2007 Jun 14.

PMID:
17569750
[PubMed - indexed for MEDLINE]
Free Article
11.

Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Dec;50(12):3856-65.

PMID:
15593217
[PubMed - indexed for MEDLINE]
Free Article
12.

Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.

Tian J, Chen JW, Gao JS, Li L, Xie X.

Rheumatol Int. 2013 Jul;33(7):1829-35. doi: 10.1007/s00296-012-2657-0. Epub 2013 Jan 18.

PMID:
23328930
[PubMed - indexed for MEDLINE]
13.

The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, van den Hoogen FH, van den Berg WB, Radstake TR.

Arthritis Rheum. 2005 Aug;52(8):2313-22.

PMID:
16052591
[PubMed - indexed for MEDLINE]
Free Article
14.

The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.

Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, Giddins G, Feldmann M, Brennan F, Foxwell BM.

Am J Pathol. 2007 Feb;170(2):518-25.

PMID:
17255320
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.

Wähämaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, Harris HE.

Arthritis Res Ther. 2011 Aug 26;13(4):R136. doi: 10.1186/ar3450.

PMID:
21871094
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.

Miller LE, Grifka J, Schölmerich J, Straub RH.

J Rheumatol. 2002 Mar;29(3):427-35. Erratum in: J Rheumatol. 2003 May;30(5):1125.

PMID:
11908553
[PubMed - indexed for MEDLINE]
17.

Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.

Badot V, Durez P, Van den Eynde BJ, Nzeusseu-Toukap A, Houssiau FA, Lauwerys BR.

J Cell Mol Med. 2011 Nov;15(11):2335-42. doi: 10.1111/j.1582-4934.2010.01228.x.

PMID:
21129157
[PubMed - indexed for MEDLINE]
18.

IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor.

Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, Tomita T, Ochi T, Yoshizaki K.

Int Immunol. 2000 Feb;12(2):187-93.

PMID:
10653854
[PubMed - indexed for MEDLINE]
Free Article
19.

Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.

Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K.

J Rheumatol. 2009 Nov;36(11):2397-402. doi: 10.3899/jrheum.090132. Epub 2009 Oct 1.

PMID:
19797510
[PubMed - indexed for MEDLINE]
20.

Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network.

Kontny E, Plebanczyk M, Lisowska B, Olszewska M, Maldyk P, Maslinski W.

Ann Rheum Dis. 2012 Feb;71(2):262-7. doi: 10.1136/annrheumdis-2011-200123. Epub 2011 Oct 11.

PMID:
21989538
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk